Client’s Testimonial:
“Thank you so much for your message and for the wonderful news regarding the approval of my I-140 EB1A petition. I am incredibly grateful for your outstanding support, expertise, and professionalism throughout this process. From the very beginning, your team demonstrated deep knowledge of the EB1A category, provided clear guidance, and delivered high-quality drafts and responses that gave me confidence at every step. Your strategic advice, attention to detail, and timely communication truly made all the difference.”
On March 31st, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Senior Scientist in the Field of Biomedical Sciences (Approval Notice).
General Field: Biomedical Sciences
Position at the Time of Case Filing: Senior Scientist
Country of Origin: India
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: March 31st, 2025
Processing Time: 6 months, 6 days (Premium Processing Requested)
Case Summary:
A distinguished biomedical scientist recently obtained EB-1A (Alien of Extraordinary Ability) approval with the support of North America Immigration Law Group (NAILG). Known for his contributions to infectious disease research, vaccine development, and immunology, His work is making a meaningful impact on public health efforts both in the United States and around the world.
When he approached NAILG to assist with his EB-1A petition, our team conducted a comprehensive review of his academic accomplishments and professional record. Confident in the merit and national relevance of his work, we prepared a strong petition highlighting his leadership in biomedical science and his critical role in advancing therapeutic innovation.
Our client’s research focuses on understanding complex biological systems involved in disease and immunity. His studies have led to major advances, including elucidating the structure and polymerization of septin complexes in human cells, identifying the role of angiostatin in neutrophil biology, and introducing rapid multiplex PCR for the timely diagnosis of typhoid fever. These findings support the development of more effective vaccines, diagnostics, and treatments for a range of diseases.
Key achievements included in his petition:
- 8 peer-reviewed journal articles (4 first-authored).
- At least 10 completed peer reviews for scientific journals.
- 174 total citations across at least 33 countries.
His scientific leadership was further affirmed through expert testimonials. One recommender emphasized:
“[Client]’s research has a direct impact on the development of effective vaccines and therapeutics to treat major illnesses, ranging from infectious diseases to neurodegenerative disorders and cancer. His continued work in these areas is of clear national importance.”
Our client’s EB-1A approval reflects both the outstanding quality of his research and its relevance to public health, biomedical innovation, and global disease management. We are honored to have supported him in achieving this milestone and are confident he will continue to contribute meaningfully to advancing science and improving healthcare outcomes.
North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).
Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend
With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.
We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours
With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.
Vast Majority of Clients Came to Us Because of Referrals
For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.

Approval Notices: https://www.wegreened.com/eb1_niw_approvals
Success Stories: https://www.wegreened.com/blog/
Website: www.wegreened.com
Free evaluation: https://www.wegreened.com/Free-Evaluation
Tel: 888.666.0969 (Toll Free)
To see more clients’ testimonials and approvals, please refer to:
To Learn More About Your Options CLICK HERE
Copyright © North America Immigration Law Group – WeGreened.com, All Rights Reserved.